Analyst Sees Attractive Entry Opportunity After BioCryst’s Pipeline Setback
Tucked in its Q4 earnings press release, BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) reported a setback on the early-stage BCX10013 study. The company…
Nordson’s Steps To Diversify Despite Volatility, Margin Boost Initiatives Win Analyst Attention Who Prefers Buying The Dips
KeyBanc analyst Jeffrey Hammond upgraded Nordson Corp (NASDAQ:NDSN) from Sector Weight to Overweight and a $255 price target. Nordson reported Q1 sales…
Needham Upgrades BioCryst Pharmaceuticals to Buy, Maintains $14 Price Target
Needham analyst Serge Belanger upgrades BioCryst Pharmaceuticals (NASDAQ:BCRX) from Hold to Buy and maintains $14 price target.
Raymond James Upgrades Masimo to Outperform, Announces $187 Price Target
Raymond James analyst Jayson Bedford upgrades Masimo (NASDAQ:MASI) from Market Perform to Outperform and announces $187 price target.
DA Davidson Upgrades Shopify to Buy, Announces $50 Price Target
DA Davidson analyst Gil Luria upgrades Shopify (NYSE:SHOP) from Neutral to Buy and announces $50 price target.
Citigroup Upgrades Alcoa to Buy, Raises Price Target to $65
Citigroup analyst Alexander Hacking upgrades Alcoa (NYSE:AA) from Neutral to Buy and raises the price target from $55 to $65.
Keybanc Upgrades Nordson to Overweight, Announces $255 Price Target
Keybanc analyst Jeffrey Hammond upgrades Nordson (NASDAQ:NDSN) from Sector Weight to Overweight and announces $255 price target.
Janney Montgomery Scott Upgrades HomeTrust Bancshares to Buy
Janney Montgomery Scott analyst Feddie Strickland upgrades HomeTrust Bancshares (NASDAQ:HTBI) from Neutral to Buy.
Raymond James Upgrades Glacier Bancorp to Outperform, Announces $51 Price Target
Raymond James analyst Michael Rose upgrades Glacier Bancorp (NYSE:GBCI) from Market Perform to Outperform and announces $51 price target.
Raymond James Upgrades Trustmark to Outperform, Announces $34 Price Target
Raymond James analyst Michael Rose upgrades Trustmark (NASDAQ:TRMK) from Market Perform to Outperform and announces $34 price target.